Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ali

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Journal of Substance Abuse Treatment|April 29, 2005
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Shane Darke, Joanne Ross, Maree Teesson, et al.
Drug and Alcohol Dependence|December 28, 2020
Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesNicola R Jones, Suzanne Nielsen, Michael Farrell, et al.
Drug and Alcohol Review|March 28, 2008
The rise of methamphetamine in Southeast and East AsiaRebecca McKetin, Nicholas Kozel, Jeremy Douglas, et al.
Drug and Alcohol Dependence|May 6, 2022
The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage studyNicola R Jones, Matthew Hickman, Suzanne Nielsen, et al.
British Journal of Clinical Pharmacology|November 27, 2008
Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamicsAndrew A Somogyi, Mie Larsen, Reza M Abadi, et al.
Drug and Alcohol Dependence|July 20, 2016
Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary studyAmy Peacock, Raimondo Bruno, Briony Larance, et al.
Drug and Alcohol Review|December 9, 2003
Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severityRobert Ali, Peter Thomas, Jason White, et al.
Drug and Alcohol Review|July 17, 2015
Injecting buprenorphine-naloxone film: Findings from an explorative qualitative studyNancy White, Ian Flaherty, Peter Higgs, et al.
British Journal of Clinical Pharmacology|November 4, 2004
Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centreJaroon Jittiwutikarn, Robert Ali, Jason M White, et al.
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Journal of Substance Abuse Treatment|April 29, 2005
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Shane Darke, Joanne Ross, Maree Teesson, et al.
Drug and Alcohol Dependence|December 28, 2020
Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomesNicola R Jones, Suzanne Nielsen, Michael Farrell, et al.
Drug and Alcohol Review|March 28, 2008
The rise of methamphetamine in Southeast and East AsiaRebecca McKetin, Nicholas Kozel, Jeremy Douglas, et al.
Drug and Alcohol Dependence|May 6, 2022
The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage studyNicola R Jones, Matthew Hickman, Suzanne Nielsen, et al.
British Journal of Clinical Pharmacology|November 27, 2008
Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamicsAndrew A Somogyi, Mie Larsen, Reza M Abadi, et al.
Drug and Alcohol Dependence|July 20, 2016
Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary studyAmy Peacock, Raimondo Bruno, Briony Larance, et al.
Drug and Alcohol Review|December 9, 2003
Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severityRobert Ali, Peter Thomas, Jason White, et al.
Drug and Alcohol Review|July 17, 2015
Injecting buprenorphine-naloxone film: Findings from an explorative qualitative studyNancy White, Ian Flaherty, Peter Higgs, et al.
British Journal of Clinical Pharmacology|November 4, 2004
Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centreJaroon Jittiwutikarn, Robert Ali, Jason M White, et al.
The Lancet. Psychiatry|January 17, 2018
The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) studyBriony Larance, Timothy Dobbins, Amy Peacock, et al.
Pageof 12